These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The medical management of reflux esophagitis. Role of antacids and acid inhibition. Sontag SJ Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703 [TBL] [Abstract][Full Text] [Related]
3. Long-term management of gastroesophageal reflux disease and its complications. Richter JE Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624 [TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease. Garnett WR Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S11-8. PubMed ID: 8097363 [TBL] [Abstract][Full Text] [Related]
6. Medical treatment of gastro-oesophageal reflux disease. De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932 [TBL] [Abstract][Full Text] [Related]
7. [Conservative treatment of florid peptic esophageal stenosis. Complete elimination by dilatation and omeprazole in H2-blocker refractory cases]. Koop H; Katschinski M; Arnold R Med Klin (Munich); 1991 Nov; 86(11):566-8. PubMed ID: 1685214 [TBL] [Abstract][Full Text] [Related]
8. Management of gastro-oesophageal reflux disease. Are there alternatives to omeprazole? Meuwissen SG; Klinkenberg-Knol EC Digestion; 1989; 44 Suppl 1():54-62. PubMed ID: 2575062 [TBL] [Abstract][Full Text] [Related]
9. Omeprazole therapy decreases the need for dilatation of peptic oesophageal strictures. Barbezat GO; Schlup M; Lubcke R Aliment Pharmacol Ther; 1999 Aug; 13(8):1041-5. PubMed ID: 10468679 [TBL] [Abstract][Full Text] [Related]
10. Gastro-oesophageal reflux disease. de Carle DJ Med J Aust; 1998 Nov; 169(10):549-54. PubMed ID: 9861914 [TBL] [Abstract][Full Text] [Related]
11. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy. Klinkenberg-Knol EC; Meuwissen SG Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868 [TBL] [Abstract][Full Text] [Related]
15. Gastroesophageal reflux disease. Williams CN Can J Gastroenterol; 1998 Mar; 12(2):107-8. PubMed ID: 9559205 [TBL] [Abstract][Full Text] [Related]
16. Reflux esophagitis in infants and children: a report from the Working Group on Gastro-Oesophageal Reflux Disease of the European Society of Paediatric Gastroenterology and Nutrition. Vandenplas Y J Pediatr Gastroenterol Nutr; 1994 May; 18(4):413-22. PubMed ID: 7915307 [TBL] [Abstract][Full Text] [Related]
17. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials. Koelz HR Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015 [TBL] [Abstract][Full Text] [Related]
18. Omeprazole in H2 receptor antagonist-resistant reflux esophagitis. Marciano-D'Amore DA; Paterson WG; Da Costa LR; Beck IT J Clin Gastroenterol; 1990 Dec; 12(6):616-20. PubMed ID: 1979984 [TBL] [Abstract][Full Text] [Related]